SEC Comment Letter 0000000000-26-004953 to NewcelX Ltd. (NCEL)
NewcelX Ltd.
Date: May 14, 2026 · CIK: 0001783036 · Accession: 0000000000-26-004953
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295770
Letter
May 14, 2026 Omri Hagai Chief Financial Officer NewcelX Ltd. Hohstrasse 1 8302 Kloten, Switzerland Re: NewcelX Ltd. Registration Statement on Form F-3 Filed May 11, 2026 File No. 333-295770 Dear Omri Hagai: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Gary Emmanuel
Show Raw Text
May 14, 2026 Omri Hagai Chief Financial Officer NewcelX Ltd. Hohstrasse 1 8302 Kloten, Switzerland Re: NewcelX Ltd. Registration Statement on Form F-3 Filed May 11, 2026 File No. 333-295770 Dear Omri Hagai: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Gary Emmanuel